Development of thrombolytic agents
- 31 December 1993
- journal article
- review article
- Published by Elsevier in Biotechnology Advances
- Vol. 11 (1) , 115-130
- https://doi.org/10.1016/0734-9750(93)90411-f
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Comparative thrombolytic and immunogenic properties of staphylokinase and streptokinaseFibrinolysis, 1992
- Purifying antibody-plasminogen activator conjugatesBioconjugate Chemistry, 1992
- K1K2Pu, a recombinant t-PA/u-PA Chimera with increased thrombolytic potency, consisting of amino acids 1 to 3 and 87 to 274 of human tissue-type plasminogen activator (t-PA) and amino acids 138 to 411 of human single chain urokinase-type plasminogen activator (scu-PA). Purification in centigram quantities and conditioning for use in manThrombosis Research, 1992
- Basic and clinical aspects of fibrinolysis and thrombolysisBlood, 1991
- Thrombolytic and pharmacokinetic properties of chimeric tissue-type and urokinase-type plasminogen activators.Circulation, 1991
- Platelet-targeted fibrinolysis enhances clot lysis and inhibits platelet aggregation.Circulation, 1991
- Thrombolytic and pharmacokinetic properties of a conjugate of recombinant single-chain urokinase-type plasminogen activator with a monoclonal antibody specific for cross-linked fibrin in a baboon venous thrombosis model.Circulation, 1990
- Conjugation to antifibrin Fab' enhances fibrinolytic potency of single-chain urokinase plasminogen activator.Circulation, 1990
- Thrombolytic and pharmacokinetic properties of conjugates of urokinase-type plasminogen activator with a monoclonal antibody specific for crosslinked fibrinFibrinolysis, 1989
- On the Regulation and Control of FibrinolysisThrombosis and Haemostasis, 1980